课题基金 / 基金详情

Effects of Osteocalcin and Osteopontin on Damage Morphology and Bone Fragility

Effects of Osteocalcin and Osteopontin on Damage Morphology and Bone Fragility
骨钙素和骨桥蛋白对损伤形态和骨脆性的影响
批准号:
7987773
负责人:
Deepak Vashishth
金额:
$36.21万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-30 至 2015-08-31

项目摘要

项目成果

Deepak Vashishth的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Although lower bone mass is associated with increased bone fragility, studies conducted during the last grant cycle demonstrated that the mode and magnitude of microdamage formation affects bone's resistance to fracture or 'toughness'. Bones from younger donors are superior in toughness and form diffuse damage as the prominent morphology of microdamage. In contrast, bones from older donors predominantly form linear microcracks that coalesce to cause fracture. The basis of this unique association between damage morphology and toughness is not known. Our preliminary studies show for the first time that diffuse damage in bone initiates in the form of dilatational bands between the fused mineralized aggregates. Dilatational bands stain positive for osteocalcin (OC) and osteopontin (OPN). OC and OPN are present in higher amounts in diffuse damage areas than in controls and the deletion of OC or phosphorylation of bone matrix decreases toughness. Because OPN and OC vary with tissue and donor age, and are intimately associated with each other and with bone mineral where dilatational bands and diffuse damage form, the modification and loss of these non-collagenous matrix proteins may determine the damage morphology and bone's propensity to fracture. Thus the overall goal of this project is to investigate the role of OC and OPN in age-related bone fragility. Bones from human cadavers, aging mouse and transgenic (knock-outs-/- & hetrozygotes) mice including OC-/-, OC, OPN-/- OPN, OPN-OC-/- and OPN-OC and their controls will be subjected to mechanical and immunohistochemical evaluations to investigate whether: (H1): The deletion or modification of OC and or OPN in bone increases bone fragility and bone's propensity to form linear microcracks over diffuse damage; (H2) The age-related increase in bone fragility is associated with the modification and loss of OC and/or OPN that co-localize differently with diffuse damage and linear microcracks. Since OC and OPN levels can be manipulated through hormones and mechanical loading, the evidence of their new direct relationship to damage formation and bone fragility will lead to the development of novel modalities for predicting fracture, as well as strategies for improving bone quality and reducing the fracture risk. PUBLIC HEALTH RELEVANCE: Aging and disease may alter bone matrix and predispose an individual to a higher fracture risk. This project will identify the effects of the modifications and/or loss of two key bone proteins, osteocalcin and osteopontin, on age-related fragility fractures. This new information will lead to the development of novel modalities for predicting fracture, as well as strategies for improving bone quality and reducing the fracture risk.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effects of Advanced Glycation Endproducts on Type 2 Diabetic and Fragility Fractures
  • 批准号:
    10672317
  • 项目类别:
  • 资助金额:
    $59.34万
  • 财政年份:
    2022
  • 负责人:
    Deepak Vashishth
  • 依托单位:
Effects of Advanced Glycation Endproducts on Type 2 Diabetic and Fragility Fractures
  • 批准号:
    10522698
  • 项目类别:
  • 资助金额:
    $59.88万
  • 财政年份:
    2022
  • 负责人:
    Deepak Vashishth
  • 依托单位:
BIOMOLECULAR SCIENCE AND ENGINEERING TRAINING PROGRAM
  • 批准号:
    10415924
  • 项目类别:
  • 资助金额:
    $41.63万
  • 财政年份:
    2021
  • 负责人:
    Deepak Vashishth
  • 依托单位:
BIOMOLECULAR SCIENCE AND ENGINEERING TRAINING PROGRAM
  • 批准号:
    10207046
  • 项目类别:
  • 资助金额:
    $39.01万
  • 财政年份:
    2021
  • 负责人:
    Deepak Vashishth
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: